PepGen Inc
PEPG4.210USD
-0.330-7.27%
收盤 11/06, 16:00（美東）報價延遲15分鐘
138.09M總市值
虧損本益比TTM
關於 PepGen Inc 公司
PepGen Inc. 是一家臨牀階段的生物技術公司。該公司致力於推進下一代寡核苷酸療法，旨在改變嚴重神經肌肉和神經系統疾病的治療方法。其專有的增強遞送寡核苷酸 (EDO) 平臺利用細胞穿透肽來改善結合寡核苷酸療法的吸收和活性。其 EDO 肽經過精心設計，可優化組織滲透、細胞吸收和核遞送。利用這些 EDO 肽，該公司正在生成一系列寡核苷酸治療候選藥物，旨在針對嚴重疾病的根本原因。該公司的管線包括兩個臨牀階段項目：用於適合外顯子 51 跳躍的杜氏肌營養不良症 (DMD) 患者的 PGN-EDO51 和用於 1 型肌強直性營養不良症 (DM1) 患者的 PGN-EDODM1。它還有另外三個臨牀前階段項目：PGN-EDO53、PGN-EDO45 和 PGN-EDO44。
PepGen Inc簡介
公司代碼PEPG
公司名稱PepGen Inc
上市日期May 06, 2022
CEODr. James G. Mcarthur, Ph.D.
員工數量81
證券類型Ordinary Share
年結日May 06
公司地址245 Main St, 2nd Floor
城市CAMBRIDGE
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編02142
電話17034568000
網址https://pepgen.com
公司代碼PEPG
上市日期May 06, 2022
CEODr. James G. Mcarthur, Ph.D.
PepGen Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. James G. Mcarthur, Ph.D.
Dr. James G. Mcarthur, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
53.19K
+3040.14%
Ms. Laurie Bartlett Keating, J.D.
Ms. Laurie Bartlett Keating, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
4.17K
--
Ms. Mary Beth Delena, J.D.
Ms. Mary Beth Delena, J.D.
General Counsel, Company Secretary
General Counsel, Company Secretary
1.43K
-8.67%
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Director
Independent Director
--
--
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
--
--
Dr. Paul D. Streck, M.D.
Dr. Paul D. Streck, M.D.
Executive Vice President, Head of Research & Development
Executive Vice President, Head of Research & Development
--
--
Mr. Noel P. Donnelly
Mr. Noel P. Donnelly
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Joshua B. (Josh) Resnick, M.D.
Dr. Joshua B. (Josh) Resnick, M.D.
Independent Director
Independent Director
--
--
Dr. Howard Mayer, M.D.
Dr. Howard Mayer, M.D.
Independent Director
Independent Director
--
--
Dr. Kasra Kasraian, Ph.D.
Dr. Kasra Kasraian, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. James G. Mcarthur, Ph.D.
Dr. James G. Mcarthur, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
53.19K
+3040.14%
Ms. Laurie Bartlett Keating, J.D.
Ms. Laurie Bartlett Keating, J.D.
Independent Chairman of the Board
Independent Chairman of the Board
4.17K
--
Ms. Mary Beth Delena, J.D.
Ms. Mary Beth Delena, J.D.
General Counsel, Company Secretary
General Counsel, Company Secretary
1.43K
-8.67%
Mr. Habib Joseph Dable
Mr. Habib Joseph Dable
Independent Director
Independent Director
--
--
Ms. Heidi Henson, CPA
Ms. Heidi Henson, CPA
Independent Director
Independent Director
--
--
Dr. Paul D. Streck, M.D.
Dr. Paul D. Streck, M.D.
Executive Vice President, Head of Research & Development
Executive Vice President, Head of Research & Development
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 8月19日 週二
更新時間: 8月19日 週二
持股股東
股東類型
持股股東
持股股東
佔比
RA Capital Management, LP
29.19%
Oxford Science Enterprises PLC
7.21%
Viking Global Investors LP
5.07%
Point72 Asset Management, L.P.
4.01%
Millennium Management LLC
2.20%
其他
52.32%
持股股東
持股股東
佔比
RA Capital Management, LP
29.19%
Oxford Science Enterprises PLC
7.21%
Viking Global Investors LP
5.07%
Point72 Asset Management, L.P.
4.01%
Millennium Management LLC
2.20%
其他
52.32%
股東類型
持股股東
佔比
Venture Capital
36.40%
Hedge Fund
12.46%
Investment Advisor/Hedge Fund
5.92%
Investment Advisor
2.67%
Sovereign Wealth Fund
1.81%
Research Firm
0.25%
Individual Investor
0.13%
其他
40.36%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
157
40.91M
59.52%
+1.09M
2025Q2
165
31.28M
95.59%
-5.47M
2025Q1
168
31.44M
96.09%
-5.26M
2024Q4
160
31.09M
95.12%
-3.10M
2024Q3
156
31.41M
96.35%
-1.62M
2024Q2
150
31.22M
97.59%
-974.84K
2024Q1
140
30.76M
96.24%
+4.98M
2023Q4
127
22.26M
93.52%
+3.25M
2023Q3
124
22.70M
95.37%
+3.35M
2023Q2
119
23.17M
97.35%
+3.81M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
RA Capital Management, LP
20.06M
29.19%
+9.38M
+87.70%
Sep 26, 2025
Oxford Science Enterprises PLC
4.96M
7.21%
+200.00K
+4.21%
Sep 30, 2025
Viking Global Investors LP
3.48M
5.07%
+2.00M
+134.91%
Sep 26, 2025
Point72 Asset Management, L.P.
2.76M
4.01%
+83.23K
+3.11%
Jun 30, 2025
Millennium Management LLC
1.51M
2.2%
+476.18K
+46.10%
Jun 30, 2025
Adage Capital Management, L.P.
1.35M
1.96%
--
--
Jun 30, 2025
Qatar Investment Authority
1.24M
1.81%
--
--
Sep 30, 2024
The Vanguard Group, Inc.
937.02K
1.36%
+37.29K
+4.14%
Jun 30, 2025
Laurion Capital Management LP
810.76K
1.18%
--
--
Jun 30, 2025
Woodline Partners LP
691.53K
1.01%
-89.37K
-11.44%
Jun 30, 2025
查看更多
持股ETF
更新時間: 17 小時前
更新時間: 17 小時前
機構名稱
佔比
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Micro-Cap ETF
0.02%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.01%
Proshares Ultra Russell 2000
0%
Invesco Dorsey Wright SmallCap Momentum ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
查看更多
ProShares Ultra Nasdaq Biotechnology
佔比0.02%
iShares Micro-Cap ETF
佔比0.02%
Invesco Nasdaq Biotechnology ETF
佔比0.02%
iShares Biotechnology ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
ProShares Hedge Replication ETF
佔比0%
DFA Dimensional US Sustainability Core 1 ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
